ArticleJournal of health economics and outcomes research2024

Cost-Utility Analysis of Add-on Cannabidiol vs Usual Care Alone for the Treatment of Seizures in Patients With Treatment-Resistant Lennox-Gastaut Syndrome or Dravet Syndrome in the Netherlands.

Jamshaed Siddiqui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.